Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.04 | 0.8 |
mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.041 | 0.8 |
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |